THERAPEUTIC USE OF A TLR AGONIST AND COMBINATION THERAPY
- 专利权人:
- 发明人:
- 申请号：
- EP11830073.0
- 公开号：
- EP2621500B1
- 申请日:
- 2011.10.03
- 申请国别(地区):
- EP
- 年份:
- 2016
- 代理人:
- 摘要：
- The present invention is directed generally to formulations of a TLR agonist preferably a TLR8 agonist, and its use in the treatment of various diseases, including combination therapies for treating cancer.
- 来源网站：
- 中国工程科技知识中心
